Contineum Therapeutics · Small Molecule · Phase 1/2
CompletedTherapeutic
Evidence
trial
Confidence
86%
Indications
Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy
Population
Adult
Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.